|
References Adhikary L, Chow F, Nikolic-Paterson DJ, Stambe C, Dowling J, Atkins RC, Tesch GH (2004). Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia 47:1210-1222. Anders HJ, Ninichuk V, Schlondorff D (2006). Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 69:29-32. Anders HJ, Vielhauer V, Schlondorff D (2003). Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63:401-415. Atkins RC (1995). Interleukin-1 in crescentic glomerulonephritis. Kidney Int 48:576-586. Bazzoni F, Beutler B (1996). The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725. Board R, Jayson GC (2005). Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics. Drug Resist Updat 8:75-83. Bonizzi G, Karin M (2004). The two NF-B activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280-288. Bradley JR (2008). TNF-mediated inflammatory disease. J Pathol 214:149-160. Breitwieser W, Lyons S, Flenniken AM, Ashton G, Bruder G, Willington M, Lacaud G, Kouskoff V, Jones N (2007). Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev 21:2069-2082. Carvalho-Pinto CE, Garcia MI, Mellado M, Rodriguez-Frade JM, Martin-Caballero J, Flores J, Martinez A, Balomenos D (2002). Autocrine production of IFN- by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice. J Immunol 169:1058-1067. Chung JY, Park YC, Ye H, Wu H (2002). All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115:679-688. Couchman JR, Beavan LA, McCarthy KJ (1994). Glomerular matrix: synthesis, turnover and role in mesangial expansion. Kidney Int 45:328-335. Curnock AP, Ward SG (2003). Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling. J Immunol Methods 273:29-41. Dal CA (1995). Adhesion molecules in renal disease. Kidney Int 48:1687-1696. Danese S, Semeraro S, Marini M, Roberto I, Armuzzi A, Papa A, Gasbarrini A (2005). Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig Liver Dis 37:811-818. Danielsen AJ, Maihle NJ (2002). The EGF/ErbB receptor family and apoptosis. Growth Factors 20:1-15. Davies M (1994). The mesangial cell: a tissue culture view. Kidney Int 45:320-327. De BK, Vanden BW, Haegeman G (2003). The interplay between the glucocorticoid receptor and nuclear factor-B or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488-522. De CP, Starace D, Starace G, Filippini A, Stefanini M, Ziparo E (1999). Activation of Jun N-terminal kinase/stress-activated protein kinase pathway by tumor necrosis factor leads to intercellular adhesion molecule-1 expression. J Biol Chem 274:28978-28982. Ding G, Zhang A, Huang S, Pan X, Zhen G, Chen R, Yang T (2007). ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. Am J Physiol Renal Physiol 293:F1889-F1897. Egido J, Gomez-Chiarri M, Ortiz A, Bustos C, Alonso J, Gomez-Guerrero C, Gomez-Garre D, Lopez-Armada MJ, Plaza J, Gonzalez E (1993). Role of tumor necrosis factor- in the pathogenesis of glomerular diseases. Kidney Int Suppl 39:S59-S64. Elangbam CS, Qualls CW, Jr., Dahlgren RR (1997). Cell adhesion molecules--update. Vet Pathol 34:61-73. Ernandez T, Mayadas T (2009). Immunoregulatory role of TNF in inflammatory kidney diseases. Kidney Int. Feldmann M, Pusey CD (2006). Is there a role for TNF- in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases. J Am Soc Nephrol 17:1243-1252. Francescato HD, Costa RS, Junior FB, Coimbra TM (2007). Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol Dial Transplant 22:2138-2148. Fresno Vara JA, Casado E, de CJ, Cejas P, Belda-Iniesta C, Gonzalez-Baron M (2004). PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30:193-204. Fujii M, Inoguchi T, Maeda Y, Sasaki S, Sawada F, Saito R, Kobayashi K, Sumimoto H, Takayanagi R (2007). Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Kidney Int 72:473-480. Gaur U, Aggarwal BB (2003). Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66:1403-1408. Ghosh S, Hayden MS (2008). New regulators of NF-B in inflammation. Nat Rev Immunol 8:837-848. Hayden MS, Ghosh S (2008). Shared principles in NF-B signaling. Cell 132:344-362. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4:988-1004. Hess J, Angel P, Schorpp-Kistner M (2004). AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117:5965-5973. Hsieh HL, Sun CC, Wang TS, Yang CM (2008). PKC-/c-Src-mediated EGF receptor transactivation regulates thrombin-induced COX-2 expression and PGE(2) production in rat vascular smooth muscle cells. Biochim Biophys Acta 1783:1563-1575. Huang S, Zhang A, Ding G, Chen R (2009). Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation. Am J Physiol Renal Physiol 296:F1323-F1333. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC (1992). Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323-16329. Ijaz A, Tejada T, Catanuto P, Xia X, Elliot SJ, Lenz O, Jauregui A, Saenz MO, Molano RD, Pileggi A, Ricordi C, Fornoni A (2009). Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney Int 75:381-388. Ishizawa K, Yoshizumi M, Tsuchiya K, Houchi H, Minakuchi K, Izawa Y, Kanematsu Y, Kagami S, Hirose M, Tamaki T (2004). Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res 27:433-440. Jaken S (1996). Protein kinase C isozymes and substrates. Curr Opin Cell Biol 8:168-173. Jiang BH, Zheng JZ, Aoki M, Vogt PK (2000). Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 97:1749-1753. Karin M, Gallagher E (2009). TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol Rev 228:225-240. Karin M, Greten FR (2005). NF-B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759. Karin M, Liu Z, Zandi E (1997). AP-1 function and regulation. Curr Opin Cell Biol 9:240-246. Kreisberg JI, Venkatachalam M, Troyer D (1985). Contractile properties of cultured glomerular mesangial cells. Am J Physiol 249:F457-F463. Lan HY (2008). Role of macrophage migration inhibition factor in kidney disease. Nephron Exp Nephrol 109:e79-e83. Lee CW, Lin CC, Lin WN, Liang KC, Luo SF, Wu CB, Wang SW, Yang CM (2007). TNF- induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-B/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292:L799-L812. Lee CW, Lin CC, Luo SF, Lee HC, Lee IT, Aird WC, Hwang TL, Yang CM (2008). Tumor necrosis factor- enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells. Mol Pharmacol 73:1454-1464. Lee YJ, Han HJ (2008). Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-B signal pathways in renal proximal tubule cells. Am J Physiol Renal Physiol 294:F534-F541. Li J, Campanale NV, Liang RJ, Deane JA, Bertram JF, Ricardo SD (2006). Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy. Am J Pathol 169:1527-1540. Li S, Wang L, Dorf ME (2009). PKC phosphorylation of TRAF2 mediates IKK/ recruitment and K63-linked polyubiquitination. Mol Cell 33:30-42. Little MA, Bhangal G, Smyth CL, Nakada MT, Cook HT, Nourshargh S, Pusey CD (2006). Therapeutic effect of anti-TNF- antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis. J Am Soc Nephrol 17:160-169. Liu Y, Shepherd EG, Nelin LD (2007). MAPK phosphatases--regulating the immune response. Nat Rev Immunol 7:202-212. Ma FY, Tesch GH, Flavell RA, Davis RJ, Nikolic-Paterson DJ (2007). MKK3-p38 signaling promotes apoptosis and the early inflammatory response in the obstructed mouse kidney. Am J Physiol Renal Physiol 293:F1556-F1563. Masuya M, Drake CJ, Fleming PA, Reilly CM, Zeng H, Hill WD, Martin-Studdard A, Hess DC, Ogawa M (2003). Hematopoietic origin of glomerular mesangial cells. Blood 101:2215-2218. Meager A (1999). Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 10:27-39. Mocellin S, Rossi CR, Pilati P, Nitti D (2005). Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 16:35-53. Mochly-Rosen D, Gordon AS (1998). Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 12:35-42. Morel J, Berenbaum F (2004). Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 71:503-510. Myou S, Leff AR, Myo S, Boetticher E, Tong J, Meliton AY, Liu J, Munoz NM, Zhu X (2003). Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med 198:1573-1582. Navarro JF, Mora C, Maca M, Garca J (2003). Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 42:53-61. Obrig TG, Culp WJ, McKeehan WL, Hardesty B (1971). The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J Biol Chem 246:174-181. Pai R, Ha H, Kirschenbaum MA, Kamanna VS (1996). Role of tumor necrosis factor- on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. J Am Soc Nephrol 7:914-923. Park CW, Kim JH, Lee JH, Kim YS, Ahn HJ, Shin YS, Kim SY, Choi EJ, Chang YS, Bang BK (2000). High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-B-dependent. Diabetologia 43:1544-1553. Petri B, Phillipson M, Kubes P (2008). The physiology of leukocyte recruitment: an in vivo perspective. J Immunol 180:6439-6446. Petruzzelli L, Takami M, Humes HD (1999). Structure and function of cell adhesion molecules. Am J Med 106:467-476. Pfeffer K (2003). Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 14:185-191. Quaggin SE, Kreidberg JA (2008). Development of the renal glomerulus: good neighbors and good fences. Development 135:609-620. Rodriguez-Barbero A, L'Azou B, Cambar J, Lopez-Novoa JM (2000). Potential use of isolated glomeruli and cultured mesangial cells as in vitro models to assess nephrotoxicity. Cell Biol Toxicol 16:145-153. scamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de GD, Jungers P, . (1995). Balance between IL-1 TNF-, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892. Schena FP (1999). Cytokine network and resident renal cells in glomerular diseases. Nephrol Dial Transplant 14 Suppl 1:22-26. Schlondorff D (1996). Roles of the mesangium in glomerular function. Kidney Int 49:1583-1585. Schlondorff D (1987). The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1:272-281. Schlondorff D, Banas B (2009). The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179-1187. Schlondorff D, Nelson PJ, Luckow B, Banas B (1997). Chemokines and renal disease. Kidney Int 51:610-621. Schlondorff DO (2008). Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int 74:860-866. Segerer S, Nelson PJ, Schlondorff D (2000). Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11:152-176. Sen R, Baltimore D (1986). Inducibility of immunoglobulin enhancer-binding protein NF-B by a posttranslational mechanism. Cell 47:921-928. Shepard HM, Brdlik CM, Schreiber H (2008). Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family. J Clin Invest 118:3574-3581. Sheryanna A, Bhangal G, McDaid J, Smith J, Manning A, Foxwell BM, Feldmann M, Cook HT, Pusey CD, Tam FW (2007). Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1 or IL-6. J Am Soc Nephrol 18:1167-1179. Smith PC, Guerrero J, Tobar N, Caceres M, Gonzalez MJ, Martinez J (2009). Tumor necrosis factor--stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts. J Periodontal Res 44:73-80. Stambe C, Nikolic-Paterson DJ, Hill PA, Dowling J, Atkins RC (2004). p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol 15:326-336. Szlosarek PW, Balkwill FR (2003). Tumour necrosis factor : a potential target for the therapy of solid tumours. Lancet Oncol 4:565-573. Tak PP, Firestein GS (2001). NF-B: a key role in inflammatory diseases. J Clin Invest 107:7-11. Takeda S, Rogers SA, Hammerman MR (2006). Differential origin for endothelial and mesangial cells after transplantation of pig fetal renal primordia into rats. Transpl Immunol 15:211-215. Tian W, Zhang Z, Cohen DM (2000). MAPK signaling and the kidney. Am J Physiol Renal Physiol 279:F593-F604. Tipping PG, Leong TW, Holdsworth SR (1991). Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest 65:272-279. Ulbrich H, Eriksson EE, Lindbom L (2003). Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 24:640-647. Vancurova I, Miskolci V, Davidson D (2001). NF-B activation in tumor necrosis factor -stimulated neutrophils is mediated by protein kinase Cdelta. Correlation to nuclear IB. J Biol Chem 276:19746-19752. Wang HH, Hsieh HL, Wu CY, Yang CM (2009). Oxidized Low-Density Lipoprotein-Induced Matrix Metalloproteinase-9 Expression via PKC-/p42/p44 MAPK/Elk-1 Cascade in Brain Astrocytes. Neurotox Res. Wu CY, Hsieh HL, Sun CC, Tseng CP, Yang CM (2008). IL-1 induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes. J Neurochem 105:1499-1512. Wu X, Guo R, Chen P, Wang Q, Cunningham PN (2009). TNF induces caspase-dependent inflammation in renal endothelial cells through a Rho and myosin light chain kinase dependent mechanism. Am J Physiol Renal Physiol. Wuthrich RP (1992). Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney. J Am Soc Nephrol 3:1201-1211. Yamasaki T, Takahashi A, Pan J, Yamaguchi N, Yokoyama KK (2009). Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription. J Biol Chem 284:8567-8581. Yang R, Trevillyan JM (2008). c-Jun N-terminal kinase pathways in diabetes. Int J Biochem Cell Biol 40:2702-2706. Yarden Y (2001). The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer 37 Suppl 4:S3-S8. Yatabe J, Sanada H, Yatabe MS, Hashimoto S, Yoneda M, Felder RA, Jose PA, Watanabe T (2009). Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. Am J Physiol Renal Physiol 296:F1052-F1060. Young PR (1998). Pharmacological modulation of cytokine action and production through signaling pathways. Cytokine Growth Factor Rev 9:239-257. Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ (2002). Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev 22:146-167. Zhou Z, Connell MC, MacEwan DJ (2007). TNFR1-induced NF-B, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 19:1238-1248. Zhu L, Yang X, Ji Y, Chen W, Guan W, Zhou SF, Yu X (2009). Up-regulated renal expression of TNF- signalling adapter proteins in lupus glomerulonephritis. Lupus 18:116-127.
|